On (b)(6) 2008, medtronic consultant dr.(b)(6) implanted therapeutic biologic bone morphogenetic protein in combination with interbody cage(s) into patient with cd horizon supplemental fixation at (b)(6) hospital in (b)(6).The biologic is distributed under trade name capstone spine system (sizes were 26 x 12mm and 26 x 8mm).The combination of infuse and capstone cages required pma under 21 cfr 888.3080.No pma was obtained prior to commercial distribution.The capstone devices were distributed into commerce and implanted into patient nearly 7 weeks prior to receiving final clearance order on (b)(6) 2008 under k073291.Patient developed post-operative complications, including but not limited to worsening of pre-operative symptoms, bmp-induced ectopic bone growth and a cyst near the implant site.Revision surgery was conducted on (b)(6) 2010 to explant supplemental fixation devices, debride the cyst.
|